Mexican Diabetes Therapy Market

Published by: Frost & Sullivan

Published: Oct. 30, 2008

Table of Contents

1 MEXICAN MARKET INTRODUCTION AND EXECUTIVE SUMMARY

Market Introduction and Executive Summary

Executive Summary

Overview of the Mexican Healthcare System

The Diabetes Business within the Mexican Pharmaceutical Market

Mexico - Diabetes Therapy Market

Market Measurements

Industry Challenges

Market Drivers

Market Restraints

Market Forecast by Segment

Insulin

Antidiabetes Drugs

Self-monitoring Accessories

Competitive Analysis and Market Share

Insulin

Antidiabetes Drugs

Self-monitoring Accessories

Abstract

Currently in Mexico there are more than 10 million diabetics, from which only 20% is under correct control. Population growth and aging are some of the factors that keep increasing the potential for this market. Consequently increasingly more brands and products have been introduced into this market, splitting the diabetes therapy business in three segments: insulin, anti diabetes drugs and self monitoring accessories. Therefore, pharmaceutical companies face a tough competitive environment, in order to gain public and private healthcare sectors’ share.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.